Prime's Media Release Archive
2013
Prime Therapeutics appoints Ellyn Hosch as chief information officer (April 3, 2013)
Adherence to generic cholesterol-lowering drugs associated with decrease in total costs of care (April 3, 2013)
Specialty drugs will account for 50 percent of all drug costs by 2018 (April 2, 2013)
Specialty drug costs account for more than 50 percent of the total cost of care for rheumatoid arthritis and hepatitis C patients (April 2, 2013)
Prime Therapeutics earns CEO Cancer Gold Standard Accreditation (February 25, 2013)
Prime Therapeutics named a 2013 National Top Workplace (January 31, 2013)
Prime Therapeutics receives Corporate Partner Award from Multiple Sclerosis Society, Upper Midwest Chapter (January 29, 2013)
Prime Therapeutics names Ann Tobin as Chief Compliance Officer (January 28, 2013)
Prime Therapeutics earns No. 1 ranking in Inc Hire Power Award for job creation in Minnesota (December 21, 2012)
Prime Therapeutics receives Innovators in Business Award for 2012 from Florida Governor Rick Scott (December 21, 2012)
Peter Wickersham, senior vice president, cost of care at Prime Therapeutics, appointed to Pharmacy Quality Alliance Board (December 18, 2012)
PrimeMail, Prime Therapeutics' mail-service pharmacy, receives URAC Reaccreditation (December 12, 2012)
Study indicates a quarter of lung cancer patients did not receive Pharmacogenomic testing prior to start of treatment (November 30, 2012)
New study supports 15-day fill program for oral cancer medications and again demonstrates lower adherence associated with higher patient out-of-pocket costs (November 30, 2012)
BCBSNC expands Prime Therapeutics pharmacy benefit services to Medicare beneficiaries (November 29, 2012)
Prime Therapeutics recognized as one of the Achievers 50 Most Engaged Workplaces in the United States (October 25, 2012)
Eric Elliott, President and CEO at Prime Therapeutics, delivers keynote address at Therigy Specialty Pharmacy Leadership Congress (October 25, 2012)
Governor Scott introduces Prime Therapeutics to Florida (October 4, 2012)
Multiple Sclerosis (MS) specialty drug treatment cost projected to exceed $50,000 per person per year in 2016 (October 4, 2012)
Prime study shows individuals with high cholesterol who adhere to their statin medication are healthier but have higher overall costs (October 4, 2012)
Prime Therapeutics named exclusive pharmacy benefit manager for HR Policy Association (August 21, 2012)
Prime Therapeutics Announces Prime Therapeutics Specialty Pharmacy (August 1, 2012)
Prime Therapeutics announces new solution for Medicare plan comparison in collaboration with DRX (July 23, 2012)
Horizon Blue Cross Blue Shield of New Jersey Selects Prime Therapeutics for Pharmacy Benefits Management Services (June 14, 2012)
Prime Therapeutics reports one of the industry's lowest drug trends in its annual Drug Trend Insights report (June 13, 2012)
Ingrid Lindberg joins Prime Therapeutics as chief customer experience officer (June 4, 2012)
Prime Therapeutics announces enhancement to its oncology management program (May 30, 2012)
Jim DuCharme Joins Prime Therapeutics as Chief Financial Officer (May 22, 2012)
Study finds utilizing integrate? medical and pharmacy data improves ability to forecast use of high-cost specialty treatments (April 20, 2012)
Study finds generic drug discount programs requiring membership may result in incomplete PBM and health plan data (April 19, 2012)
Specialty pharmacy utilization management proves effective (April 19, 2012)
Genetic testing for new warfarin patients is rare, but often inappropriate (April 18, 2012)
Study finds improved drug duration of therapy is worth added costs (April 18, 2012)
Hypertension drug adherence associated with fewer hospitalizations and lower medical costs but increased total care costs (April 18, 2012)
Prime Therapeutics announces CareCentered Contract with EMD Serono, Inc. for MS drug Rebif (March 7, 2012)
Prime Therapeutics Announces Oncology Management Program (February 23, 2012)
Prime Therapeutics President and CEO Eric Elliott cites urgent need for "true integration" of PBMs, plans at 2012 PCMA Managed Markets Educational Forum (February 8, 2012)
Prime Therapeutics Plans Minnesota Expansion (December 20, 2011)
BCBSNC Invests in Pharmacy Benefits Manager Prime Therapeutics (December 1, 2011)
Prime Therapeutics launches retail medication therapy management program (November 15, 2011)
Study Finds New Blood Thinning Medication, Pradaxa®, Comes at High Cost (October 20, 2011)
Study Finds Children More Likely to Receive Recommended RSV Medication Doses When Administered Through Specialty Pharmacy (October 20, 2011)
Prime Therapeutics Demonstrates Willingness to Show Actual Pharmacy Costs (October 10, 2011)
Prime Therapeutics Launches CareCentered Contracting™ Program (September 22, 2011)
Prime Therapeutics Launches Development of GuidedHealth℠ Clinical Platform (September 15, 2011)
Prime Therapeutics Drug Trend Insights Reports One of the Lowest Drug Spending Increases in the Industry (August 24, 2011)
Prime Therapeutics Announces Pharmacy Offering with Guaranteed Net Spend Per P?escription (August 11, 2011)
BCBSNC Could Change Pharmacy Benefits Management Vendor to Prime Therapeutics (August 3, 2011)
Michael Showalter Joins Prime Therapeutics as Chief Marketing Officer (July 21, 2011)
Cardinal Health, Prime Therapeutics Renew Primary Distribution Agreement (June 15, 2011)
For Patients on Statins, Study Finds Filling 90 Day Supply Prescriptions through Mail Service Compared to Retail Pharmacy is Associated with Less Waste (April 27, 2011)
New Study Finds Individuals who Adhere to Their Diabetes Medication have a 31% Associated Lower Risk of Hospitalization (April 27, 2011)
Study Finds Letter to Health Care Providers Results in Reduction of Potentially Unsafe Concurrent Use of Plavix and Proton Pump Inhibitors (April 18, 2011)
Study Finds Multiple Sclerosis Pharmacy Costs Increasing Faster than Medical Costs (April 14, 2011)
Point-of-Sale Electronic Safety Check May Reduce Heart Attack Risk for Diabetic Patients (April 12, 2011)
February 16, 2011
February 8, 2011
October 28, 2010
October 19, 2010
Prime Therapeutics Receives 2011 TIPPS Certification
October 13, 2010
Prime Therapeutics Announces URAC Accreditation
October 7, 2010
Prime Therapeutics Hires Peter Wickersham, Senior Vice President Cost of Care
September 23, 2010
August 5, 2010
July 30, 2010
Prime Therapeutics Position on PBM Industry Consolidation
April 9, 2010
April 9, 2010
New Study Finds Three in Ten Women Take Common Breast Cancer Drug to Treat Infertility
April 9, 2010
New Study Finds One in Six Cancer Patients with High Out-of-Pocket Costs Not Filling Prescriptions
April 8, 2010
April 5, 2010
Blue Cross and Blue Shield of Alabama Partners with Prime Therapeutics
March 30, 2010
Prime Therapeutics to Present New Research at Academy of Managed Care Pharmacy Conference in April
Prime Therapeutics LLC (Prime), a thought leader in pharmacy benefit management, will present five new studies at the Academy of Managed Care Pharmacy's (AMCP) annual meeting, April 7-10, 2010 in San Diego.
March 29, 2010
Prime Therapeutics Announces Eric Elliott as President and CEO
Prime Therapeutics (Prime) announced today that Eric Elliott has been named as President and Chief Executive Officer of the organization.
February 16, 2010
Stacey Fahrner Joins Prime Therapeutics as Vice President,
Government Affairs
Prime Therapeutics (Prime) announced today that it has
hired Stacey Fahrner as Vice President, Government Affairs.
January 29, 2010
Prime Therapeutics Receives URAC Accreditation for Mail-Service
Pharmacy, PrimeMail
Prime Therapeutics LLC (Prime), a thought leader in
pharmacy benefit management, announced today that it has received full accreditation from the
URAC Accreditation Committee for its mail-service pharmacy, PrimeMail®.
October 13, 2009
Prime Therapeutics Receives 2010 TIPPS Certification for Adherence to High Transparency Standards
Prime Therapeutics (Prime), a thought leader in pharmacy benefit management, has
met high standards of pharmacy cost transparency, earning it 2010 Transparency in Pharmaceutical
Purchasing StandardsSM (TIPPS) certification from the HR Policy Association.
September 23, 2009
Prime Therapeutics Hires Jacqueline Chase as Senior Vice President of Human Resources
Prime Therapeutics (Prime), a nationwide pharmacy benefit management (PBM)
company, announced today that Jacqueline Chase has joined the organization as senior vice
president of human resources
September 2, 2009
Prime Therapeutics Presents on Specialty Pharmacy at BlueCross BlueShield Association's National Finance, Actuarial and Underwriting Conference
Pharmacy benefit manager Prime Therapeutics (Prime) announced
today its participation in the BlueCross BlueShield Association's 2009 National Finance,
Actuarial and Underwriting (NFAU) Conference in Boston, Massachusetts on Friday, September
11.
August 11, 2009
Prime Therapeutics 2009 Drug Trend Insights Shows Drug Spending Slows to Lowest Rate on Record
Though total health care spending in the U.S. is growing at about 6.9 percent - nearly twice the rate of inflation - pharmacy spending has increased at the lowest rate on
record for health plans served by Prime Therapeutics (Prime), a thought leader in pharmacy
benefit management.
June 17, 2009
New Study Finds 1 in 4 Multiple Sclerosis Patients with High Out-of-Pocket Costs Not Filling Prescriptions
One in four multiple sclerosis (MS) patients are declining to fill their
prescriptions likely due to high out-of-pocket costs, according to new research conducted by
pharmacy benefits manager Prime Therapeutics (Prime).
April 23, 2009
Prime Therapeutics Announces Departure of President and Chief Executive Officer Timothy Dickman
The Prime Therapeutics LLC (Prime) Board of Directors announced today
that Timothy Dickman, President and Chief Executive Officer, has left the company to pursue
other interests, effective April 23, 2009.
April 23, 2009
Prime Sponsors at 2009 American Heart Walk
Pharmacy benefit manager Prime Therapeutics (Prime) announced
today its participation in the American Heart Association's Twin Cities Start! Heart Walk.
April 14, 2009
Drug Utilization Review Reveals Potentially Inappropriate Medication Use
Among Elderly Population
Research conducted by Prime Therapeutics (Prime) revealed a significant
reduction in inappropriate prescription medication use among older adults when a retrospective
drug utilization review (RetroDUR) program paired with a provider intervention initiative was
implemented.
March 26, 2009
Prime Pharmacists Recognized by the Journal of Managed Care Pharmacy
Pharmacy benefit manager Prime Therapeutics (Prime) announced that
three of its clinical pharmacists, Patrick Gleason, PharmD, FCCP, BCPS, Cathy Starner, PharmD
and Jeremy Schafer, PharmD were awarded the Journal of Managed Care Pharmacy (JMCP)
Award of Excellence for their manuscript assessing rosiglitazone and pioglitazone utilization
trends and associated medical and pharmacy claims data indicating risk for an adverse
cardiovascular event.
January 27, 2009
Triessent® Becomes HCSC?s Specialty Pharmacy Provider
Prime Therapeutics (Prime) announced today that Health Care Service Corporation
(HCSC) has selected Triessent® as its primary specialty pharmacy program. On January 1, 2009,
Prime began providing a portion of HCSC's health benefits business with specialty pharmacy
services.
December 17, 2008
Prime Therapeutics Hires Steven Blumenfield as Chief Marketing Officer
Prime Therapeutics (Prime), a nationwide pharmacy benefit management (PBM)
company, announced today that Steven Blumenfield has joined the organization as Chief
Marketing Officer (CMO).
December 10, 2008
Prime Therapeutics Announces Blue Cross and Blue Shield of Montana
as a Pharmacy Benefit Services Client
Prime Therapeutics LLC (Prime) announces that it has been chosen
by Blue Cross and Blue Shield of Montana (BCBSMT) to provide commercial pharmacy benefit
management services, beginning January 1, 2009.
December 2, 2008
Prime Therapeutics to Provide Pharmacy Mail Service to Excellus BlueCross BlueShield Members
Prime Therapeutics (Prime) announced today it has entered into an agreement with
Rochester, New York-based Excellus BlueCross BlueShield (BCBS) to provide pharmacy mail
service to approximately 1.2 million health plan members through PrimeMail®, Prime's mailservice
pharmacy, beginning January 1, 2009.
October 20, 2008
BCBSTX is recognized to enhanced statin therapy efficiency program
Blue Cross and Blue Shield of Texas (BCBSTX), in
collaboration with Prime Therapeutics (Prime), announced today that it has implemented an award-winning
integrated medical and pharmacy claims program -- Enhancing Statin Therapy Efficiency.
September 23, 2008
Prime Therapeutics Receives 2009 TIPPS Certification
Prime Therapeutics (Prime), a thought leader in pharmacy benefit management,
announced today its 2009 Transparency in Pharmaceutical Purchasing Standards (TIPPS) certification.
August 27, 2008
Prime Therapeutics Connects Physicians to Mail Order Pharmacy
through SureScripts-RxHub Network
Prime Therapeutics, a thought leader in pharmacy benefit management, announced
today that it has completed certification with SureScripts-RxHub.
August 13, 2008
Prime Therapeutics Releases Annual Drug Trend Insights Report
Prime Therapeutics, a thought leader in pharmacy benefit management, today released its
2008 Drug Trend Insights report which revealed that its 2007 prescription drug trend increased by just
2.9 percent — the lowest annual increase it ever recorded, and less than half of what the company
recorded in 2006.
July 28, 2008
Prime Therapeutics Supports CMS Proposal to Limit Spread Pricing in Medicare Part D Administration
Prime Therapeutics (Prime) today commented on CMS's recently released proposal
to require "spread pricing" by pharmacy benefits managers (PBMs) to be appropriately
accounted for and reported as administrative costs.
June 26, 2008
Jerry Steffl Joins Prime Therapeutics as Vice President, Government Affairs
Prime Therapeutics (Prime) announced today the hiring of Jerry Steffl as Vice
President, Government Affairs
May 22, 2008
Prime Therapeutics Receives VIPPS Accreditation
Prime Therapeutics (Prime), a thought leader in pharmacy benefit management,
announced today that it has received accreditation from the National Association of Boards of
Pharmacy® (NABP®) through its Verified Internet Pharmacy Practice Sites? (VIPPS®)
Program.
May 12, 2008
Prime Therapeutics Providing Full-Service
Pharmacy Benefit Management Services to Blue Cross and Blue Shield of Oklahoma
Prime Therapeutics (Prime) announced today that it has begun providing
new services for its Blue Cross and Blue Shield of Oklahoma client. These new services mark
the beginning of Blue Cross and Blue Shield of Oklahoma as a full-service client of Prime.
April 24, 2008
Prime Hires Rachelle Wan as Vice President of Pharmaceutical Trade Relations
Prime Therapeutics (Prime), a thought leader in pharmacy benefit management,
announced today that Rachelle Wan, RPh, has joined the organization as Vice President of Pharmacy Trade Relations.
April 21, 2008
Increased Out-of-Pocket Expenses May Negatively Influence
Initiation of TNF Blocker Therapy
Prime Therapeutics (Prime), a thought leader in pharmacy benefit
management, today announced the results of its study, "Association Between Tumor Necrosis
Factor (TNF) Blocker Out-of-Pocket (OOP) Expense and Member Decline to Fill Rate".
March 25, 2008
Prime Therapeutics Introduces Triessent Specialty Pharmacy Program
Prime Therapeutics (Prime), a thought leader in pharmacy benefit management, recently announced the
launch of its specialty pharmacy program, Triessent.
February 28, 2008
Prime Therapeutics Introduces Efficiency Program to Help Employers Understand How to Most Effectively Spend Pharmacy Dollars
Prime Therapeutics launches the Efficiency Program, a targeted approach to value-based pharmacy management, that helps employers understand how to spend their limited health care dollars in ways that are most beneficial to the health of their employees.
January 30, 2008
Prime Therapeutics Becomes First PBM to Join the Center for Health Value Innovation
Prime Therapeutics (Prime) has joined the Center for Health Value Innovation as the first participant from the pharmacy benefit management (PBM) industry.
December 6, 2007
Safety Concerns Prompt Prime to Remove Avandia® from Formulary
Pharmacy benefit manager Prime Therapeutics (Prime) recently announced the removal of the prescription drug Avandia® from its national formulary. After careful examination of clinical literature regarding the safety and efficacy of Avandia, Prime's National Pharmacy and Therapeutics (P&T) Committee has made the decision to remove the drug from its formulary. Prime's P&T Committee is a panel of pharmacists and physicians that meets quarterly and reviews drugs for Prime's formulary.
December 1, 2007
Prime Therapeutics Hires Charles Roehrick as Chief Financial Officer
Prime Therapeutics (Prime), a nationwide pharmacy benefit management company, recently announced that Charles Roehrick has joined the organization as Chief Financial Officer.
November 29, 2007
Prime Therapeutics Hires Will Lambert as Vice President of Provider Network Services
Prime Therapeutics (Prime), a thought leader in pharmacy benefit management, announced today that Will Lambert has joined the organization as Vice President of Provider Network Services.
October 23, 2007
Prime Therapeutics Contracts with Blue Shield of California
Prime Therapeutics LLC (Prime) has entered into an agreement with Blue Shield of California (Blue Shield) to provide Blue Shield's mail pharmacy services, beginning January 1, 2008.
October 3, 2007
Prime Therapeutics Announces URAC Accreditation
Prime Therapeutics (Prime), a thought leader in pharmacy benefit management, announced today it has achieved URAC Pharmacy Benefit Management (PBM) accreditation.
September 6, 2007
Prime Therapeutics Receives TIPPS Certification
Prime Therapeutics (Prime), a thought leader in pharmacy benefit management, announced today its 2008 Transparency in Pharmaceutical Purchasing StandardsSM (TIPPSSM) certification.
July 16, 2007
Prime Therapeutics Hires Erin Ascher as Vice President of Human Resources
Prime Therapeutics (Prime), a thought leader in pharmacy benefit management, announced today that Erin Ascher has joined the organization as Vice President of Human Resources.
July 9, 2007
Prime Therapeutics Releases 2006 Drug Trend Insights
For the fourth consecutive year, Prime Therapeutics (Prime) reported a single digit drug trend increase for 2006. According to the pharmacy benefit management company's 2006 Drug Trend Insights, released today, Prime had a 5.9 percent increase for overall drug spending in 2006.
June 28, 2007
Prime Hires Arthur Palileo as Vice President of Enterprise Program Management and Integration
Prime Therapeutics (Prime), a thought leader in pharmacy benefit management, announced today that Arthur Palileo has joined the organization as Vice President of Enterprise Program Management and Integration.
June 12, 2007
Prime Therapeutics Announces Participation in URAC Accreditation
Prime Therapeutics (Prime), ? thought leader in pharmacy benefit management, announced today their participation in URAC's efforts to create a pharmacy benefit management (PBM) accreditation program for the commercial markets.
April 26, 2007
Prime Therapeutics Promotes Kim Mageau to Chief Operating Officer
Prime Therapeutics (Prime), a thought leader in pharmacy benefit management, announced today the promotion of Kim Mageau to Chief Operating Officer.
April 10, 2007
Study Shows Children with ADHD who Start on Strattera® are More Likely to Change Therapies
Pharmacy benefit manager Prime Therapeutics (Prime) today announced the results of a study on the utilization of Strattera® (atomoxetine) for treating attention deficit hyperactivity disorder (ADHD) in children.
January 16, 2007
Study finds 90 Percent of Actiq® "Lollipop" Prescriptions are Off-label
A recent Prime Therapeutics (Prime) study found significant patterns of "off-label" prescribing for Actiq® among patients taking the powerful painkilling "lollipop." Prescribing Actiq according to FDA guidelines is important for patient safety reasons because of the drug's serious side effects, including its addictive nature.
